168 related articles for article (PubMed ID: 14528288)
1. Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents.
Gridelli C; Rossi A; Maione P
Oncogene; 2003 Sep; 22(42):6629-38. PubMed ID: 14528288
[TBL] [Abstract][Full Text] [Related]
2. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
Maione P; Gridelli C; Troiani T; Ciardiello F
Oncologist; 2006 Mar; 11(3):274-84. PubMed ID: 16549812
[TBL] [Abstract][Full Text] [Related]
3. The role of targeted therapy in non-small cell lung cancer.
Maione P; Rossi A; Airoma G; Ferrara C; Castaldo V; Gridelli C
Crit Rev Oncol Hematol; 2004 Jul; 51(1):29-44. PubMed ID: 15207252
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract][Full Text] [Related]
5. New targeted therapies and small-cell lung cancer.
Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
[TBL] [Abstract][Full Text] [Related]
6. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
Langer C; Soria JC
Clin Lung Cancer; 2010 Mar; 11(2):82-90. PubMed ID: 20199973
[TBL] [Abstract][Full Text] [Related]
7. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
8. Triplet chemotherapy combinations with new agents: is there a rationale?
Bunn PA
Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced non-small cell lung cancer.
Shepherd FA
Semin Oncol; 1994 Aug; 21(4 Suppl 7):7-18. PubMed ID: 8091244
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed for the treatment of non-small-cell lung cancer.
Manegold C; Schmid-Bindert G; Pilz LR
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
[TBL] [Abstract][Full Text] [Related]
12. Other compounds and targets in non-small cell lung cancer.
Villaflor V; Bonomi P
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S30-6. PubMed ID: 16459177
[TBL] [Abstract][Full Text] [Related]
13. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
Langer F; Helsberg K; Schütte WH; Leschinger MI
Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
[TBL] [Abstract][Full Text] [Related]
14. Present trends in the treatment of advanced non small-cell lung cancer.
Parvez T; Allam AR; Iskandrani A; Khan MA
J Coll Physicians Surg Pak; 2003 Aug; 13(8):483-90. PubMed ID: 12921691
[TBL] [Abstract][Full Text] [Related]
15. Development of new first-line therapeutic options for non-small-cell lung cancer.
Crinò L; Foglietta J; Hamzaj A
Lung Cancer; 2006 Dec; 54 Suppl 2():S19-24. PubMed ID: 17056151
[TBL] [Abstract][Full Text] [Related]
16. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
Hotta K; Fujiwara Y; Matsuo K; Suzuki T; Kiura K; Tabata M; Takigawa N; Ueoka H; Tanimoto M
Cancer; 2007 Mar; 109(5):939-48. PubMed ID: 17285602
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer.
Wendland MM; Sause WT
Semin Surg Oncol; 2003; 21(2):111-21. PubMed ID: 14508861
[TBL] [Abstract][Full Text] [Related]
18. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of the unresectable non small cell lung carcinoma].
Spásová I
Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
[TBL] [Abstract][Full Text] [Related]
20. Current treatments for advanced stage non-small cell lung cancer.
Stinchcombe TE; Socinski MA
Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
